DRDO scientists develop Ayurveda-based drug for leucoderma

Image
ANI New Delhi
Last Updated : Nov 09 2014 | 12:10 PM IST

Defence scientists have developed a drug from medicinal plants that is proving to be effective for leucoderma (white patches on skin), considered an incurable disease.

The herbal drug, Lukoskin, has been developed by the scientists of the Defence Bio-Energy Research (DIBER), Haldwani (Uttarakhand), a laboratory of the Defence Research and Development Organisation (DRDO).

DIBER has transferred the technology of the drug, which is being showcased at the ongoing Arogya Expo 2014 alongside the sixth World ayurveda Congress, to AIMIL Pharmaceuticals India Ltd for its commercial production and sale.

Dr. Mohammad Junail of AIMIL said his company has signed an agreement with DRDO for the commercial launch of three of their herbal products.

"Lukosin has already been launched. The two other products will soon be commercially launched in Indian markets," he informed.

Leucoderma is generally considered an incurable disease, but Lukosin has been extremely effective against it. The drug is also on sale at the expo.

"The quest to cure leucoderma (Vitiligo) has finally ended with the development of the new herbal product with extensive studies by the scientists of DIBER. It can effectively combat the ailment and render the much-needed service to mankind," said Dr. W. Selvamurthy of DRDO.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 09 2014 | 11:56 AM IST

Next Story